Mylan and Upjohn, a division of Pfizer, received all necessary merger approvals. After the merger, the new company will be called Viatris and its shares will be distributed among the shareholders of Pfizer - 57% and Mylan - 43%. On November 16, 2020, the merger will be completed and the shareholders of Mylan will receive one Viatris share instead of each of their securities. After that, from November 17, Viatris shares will start trading on Nasdaq under the ticker VTRS, and trading in Mylan securities will be terminated.
Mylan and Upjohn, a division of Pfizer, received all necessary merger approvals. After the merger, the new company will be called Viatris and its shares will be distributed among the shareholders of Pfizer - 57% and Mylan - 43%. On November 16, 2020, the merger will be completed and the shareholders of Mylan will receive one Viatris share instead of each of their securities. After that, from November 17, Viatris shares will start trading on Nasdaq under the ticker VTRS, and trading in Mylan securities will be terminated. 
investor.mylan.com
English (US) 